Madsen, Christian M <br/><br/>
Lipoprotein(a)-Lowering by 50 mg/dL (105 nmol/L) May Be Needed to Reduce Cardiovascular Disease 20% in Secondary Prevention: A Population-Based Study.  [electronic resource] 

 -  Arteriosclerosis, thrombosis, and vascular biology  01 2020 
 - 255-266 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4636 
<br/><br/><label>Standard No.: </label>10.1161/ATVBAHA.119.312951  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Cardiovascular Diseases--blood<br/>Denmark--epidemiology<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Hypolipidemic Agents--therapeutic use<br/>Lipoprotein(a)--blood<br/>Male<br/>Middle Aged<br/>Morbidity--trends<br/>Population Surveillance--methods<br/>Prognosis<br/>Retrospective Studies<br/>Risk Factors<br/>Secondary Prevention--methods<br/>Time Factors<br/>Young Adult